Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmet Dag

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
JAMA Surgery|January 2, 2025
De-Escalation of Nodal Surgery in Clinically Node-Positive Breast CancerNeslihan Cabioglu, Havva Belma Koçer, Hasan Karanlik, et al.
Cancer|October 30, 2024
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is providedMahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci, et al.
European Journal of Public Health|July 8, 2025
Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in TurkiyeGuldeniz Karadeniz Cakmak, Ufuk Tali, Hakan Balbaloglu, et al.
Annals of Surgical Oncology|December 2, 2024
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03Neslihan Cabioglu, Hasan Karanlik, Abdullah Igci, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
JAMA Surgery|January 2, 2025
De-Escalation of Nodal Surgery in Clinically Node-Positive Breast CancerNeslihan Cabioglu, Havva Belma Koçer, Hasan Karanlik, et al.
Cancer|October 30, 2024
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is providedMahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci, et al.
European Journal of Public Health|July 8, 2025
Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in TurkiyeGuldeniz Karadeniz Cakmak, Ufuk Tali, Hakan Balbaloglu, et al.
Annals of Surgical Oncology|December 2, 2024
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03Neslihan Cabioglu, Hasan Karanlik, Abdullah Igci, et al.
Pageof 4